Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells

Chen Wang(Zhejiang Chinese Medical University), Jordan S. Pober(Yale University)
Journal of Clinical Investigation
March 8, 2013
Cited by 73


Related Papers